Want to see INNV full AI Analyst Report?
INNV Stock Chart & Stats
$11.56
-$0.08(-0.69%)
At close: 4:00 PM EDT
$11.56
-$0.08(-0.69%)
Day’s Range― - ―
52-Week Range$3.18 - $12.64
Previous Close$11.4
Volume236.60K
Average Volume (3M)406.68K
Market Cap
$1.52B
Enterprise Value$1.07K
Total Cash (Recent Filing)$138.60M
Total Debt (Recent Filing)$93.85M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Sep 15, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding135,736,390
10 Day Avg. Volume302,705
30 Day Avg. Volume406,683
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)2.13
Price to Sales (P/S)0.59
P/FCF Ratio18.78
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.42
Revenue Forecast (FY)$1.03B
Bulls Say, Bears Say
Bulls Say
Capitated PACE Revenue ModelThe PACE capitated model creates stable per-member recurring revenue tied to enrollment and retention, aligning incentives to manage total cost of care. Over 2–6 months this supports predictable cash flows and scalable margins as centers grow and utilization management improves.
Improving Operating MarginsMaterial margin expansion and higher adjusted EBITDA reflect durable operational improvements—better care coordination, lower facility utilization and pharmacy transitions. Sustained center-level contribution gains support reinvestment capacity and the ability to cover de novo costs long-term.
Stronger Liquidity And De‑leveragingSubstantial cash plus lower leverage provides financial flexibility to fund de novo center openings, invest in clinical/tech initiatives, and absorb cyclical Medicaid timing. Improved balance-sheet metrics reduce refinancing risk and give management runway to execute strategy.
Bears Say
GAAP Net LossesPersistent GAAP net losses reduce return on equity and leave shareholders exposed if operating improvements stall. Even with better operating cash flow, recurring non‑operating or litigation costs can keep net results negative and constrain long-term capital allocation flexibility.
Litigation‑Driven G&A VolatilityLarge, unpredictable litigation expenses inflate overhead and can erode operating leverage. If these charges persist or recur, they may negate center-level efficiency gains and force tradeoffs between growth investment and margin preservation over the medium term.
Rate Risk & Cost InflationWith revenue driven by Medicaid/Medicare capitation, constrained Medicare increases and potential Medicaid rate restraint can structurally compress revenue per member. Simultaneous wage and care cost inflation raise unit costs, squeezing margins unless offset by rate resets or stronger utilization management.
InnovAge Holding News
INNV FAQ
What was InnovAge Holding’s price range in the past 12 months?
InnovAge Holding lowest stock price was $3.17 and its highest was $12.64 in the past 12 months.
What is InnovAge Holding’s market cap?
InnovAge Holding’s market cap is $1.52B.
When is InnovAge Holding’s upcoming earnings report date?
InnovAge Holding’s upcoming earnings report date is Sep 15, 2026 which is in 35 days.
How were InnovAge Holding’s earnings last quarter?
InnovAge Holding released its earnings results on May 05, 2026. The company reported -$0.22 earnings per share for the quarter, missing the consensus estimate of $0.055 by -$0.275.
Is InnovAge Holding overvalued?
According to Wall Street analysts InnovAge Holding’s price is currently Overvalued.
Does InnovAge Holding pay dividends?
InnovAge Holding does not currently pay dividends.
What is InnovAge Holding’s EPS estimate?
InnovAge Holding’s EPS estimate is 0.07.
How many shares outstanding does InnovAge Holding have?
InnovAge Holding has 135,736,390 shares outstanding.
What happened to InnovAge Holding’s price movement after its last earnings report?
InnovAge Holding reported an EPS of -$0.22 in its last earnings report, missing expectations of $0.055. Following the earnings report the stock price went up 2.01%.
Which hedge fund is a major shareholder of InnovAge Holding?
Currently, no hedge funds are holding shares in INNV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
InnovAge Holding Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
INNV Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 203.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.8%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
204.21%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.00%
Trailing 12-Months
Company Description
InnovAge Holding
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. It serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, Florida, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 1989 and is headquartered in Denver, Colorado.
INNV Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed meaningful operational and financial momentum: strong revenue growth, material margin expansion, improved adjusted EBITDA, positive operating cash flow, raised FY2026 guidance and active reinvestment in clinical/technology capabilities. Key risks include a wider GAAP net loss driven by litigation-related corporate G&A increases, wage and care cost inflation, ongoing de novo costs, and early signs of Medicaid rate pressure for FY2027 (with modest Medicare rate growth). On balance, the company emphasized durable improvements, disciplined execution and readiness to manage near-term rate headwinds.View all INNV earnings summariesINNV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
AMN Healthcare Services
―
Brookdale Senior Living
―
Sonida Senior Living
―
―
Pennant Group
―
Ownership Overview
1.36% Insiders
4.11% Mutual Funds
0.35% Other Institutional Investors
92.37% Public Companies and
Individual Investors